Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes

scientific article published on August 2013

Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1007/S12015-011-9336-5
P698PubMed publication ID22161644
P5875ResearchGate publication ID51871261

P50authorAllison R PettitQ57051141
Nicholas M FiskQ44813090
Pascale V GuillotQ46925623
P2093author name stringJennifer M Ryan
Jerry K Y Chan
P2860cites workFormation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4Q22008002
Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissuesQ24293962
Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cellsQ24311824
Core transcriptional regulatory circuitry in human embryonic stem cellsQ24322016
Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuliQ24631307
Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cellsQ25256954
Embryonic stem cell lines derived from human blastocystsQ27861010
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementQ27861120
A perivascular origin for mesenchymal stem cells in multiple human organsQ28131808
Eleven daughters of NANOGQ28270165
A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissuesQ28291967
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cellsQ28590205
Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitorsQ30160342
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cordQ30160386
Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocolQ30164154
Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potentialQ30164557
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.Q30167892
Mesenchymal progenitor cells in human umbilical cord bloodQ30168979
Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell researchQ31162560
Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitroQ33274890
Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and futureQ33281673
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cellsQ33307769
Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheresQ33518056
Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs).Q33548649
Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cellsQ33787406
Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCsQ56915439
Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis ImperfectaQ58789209
Mesenchymal stem cells from umbilical cord: Do not discard the cord!Q60198956
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markersQ60634398
Identification of stem cell marker-positive cells by immunofluorescence in term human amnionQ64355635
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantationQ73756569
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cordQ78799982
Isolation of multipotent mesenchymal stem cells from umbilical cord bloodQ79202796
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potentialQ79334969
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placentaQ79791852
Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cellsQ79998249
Pluripotent marker expression and differentiation of human second trimester Mesenchymal Stem CellsQ80842875
Revisiting OCT4 expression in peripheral blood mononuclear cellsQ81432216
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placentaQ81529154
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenesQ81618085
Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolationQ82343448
Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermisQ82437161
Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregenerationQ82754466
Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantationQ83769039
Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterpartsQ34023300
Stemness Evaluation of Mesenchymal Stem Cells from Placentas According to Developmental Stage: Comparison to Those from Adult Bone MarrowQ34159690
Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristicsQ34529163
Isolation of amniotic stem cell lines with potential for therapyQ34598404
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker.Q34611461
Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansionQ34625007
Differential immunomodulatory effects of fetal versus maternal multipotent stromal cellsQ34880677
Fetal stem cells from extra-embryonic tissues: do not discardQ35458346
Wharton's jelly-derived cells are a primitive stromal cell populationQ35849157
Umbilical cord transplantation: epilogueQ35852921
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsQ36510839
Fetal stem cells: betwixt and betweenQ36661718
The developmental deposition of epiblast/germ cell-line derived cells in various organs as a hypothetical explanation of stem cell plasticity?Q36723465
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem CellsQ36987698
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.Q37470920
Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivationQ37547015
Differentiation and migration properties of human foetal umbilical cord perivascular cells: potential for lung repairQ37580745
Successful vitrification of human amnion-derived mesenchymal stem cells.Q38500655
Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cellsQ38512406
Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotencyQ39766924
Human chorion-derived stem cells: changes in stem cell properties during serial passageQ39794066
OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.Q39940745
Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapyQ39993682
Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease miceQ40000721
Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansionQ40034474
Characterization and differentiation of equine umbilical cord-derived matrix cellsQ40180384
Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lungQ40233552
The human OCT-4 isoforms differ in their ability to confer self-renewalQ40236055
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot studyQ40321403
Oct4 pseudogenes are transcribed in cancersQ40361157
Isolation of multipotent cells from human term placenta.Q40457999
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?Q40578057
In line with our ancestors: Oct-4 and the mammalian germQ40993926
Isolation of mesenchymal stem cells with neurogenic potential from the mesoderm of the amniotic membraneQ43136672
Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channelsQ44280495
Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layersQ44782196
Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation methodQ45239439
Human amniotic mesenchymal cells have some characteristics of cardiomyocytesQ45309359
The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1.Q45824965
Isolation and characterization of mesenchymal cells from human fetal membranesQ46882275
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta miceQ46925534
Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects.Q47172133
Ex vivo characteristics of human amniotic membrane-derived stem cellsQ48012278
Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identificationQ48156220
Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype.Q48712762
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's diseaseQ48730943
POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos.Q50645942
Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.Q50693998
Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.Q50790713
Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.Q51067770
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.Q51155330
Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration.Q51210701
Immunologic properties of human fetal mesenchymal stem cells.Q51718048
Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.Q51812638
Isolation and characterization of mesenchymal stem cells from the amniotic membrane.Q51817620
The biological characteristics of human third trimester amniotic fluid stem cells.Q51822929
Comparative growth behaviour and characterization of stem cells from human Wharton's jelly.Q51970373
Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse.Q51998594
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Q52001009
Human placenta-derived cells have mesenchymal stem/progenitor cell potential.Q52087798
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.Q53101655
Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane.Q53307976
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells.Q53531295
Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem celQ54388224
Comparison of mesenchymal stem cells from human placenta and bone marrow.Q54713607
Isolation and identification of mesenchymal stem cells from human fetal pancreas.Q54771966
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential.Q55041824
Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.Q55052510
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpluripotencyQ1894941
mesenchymal stem cellQ1922379
P304page(s)408-421
P577publication date2013-08-01
P1433published inStem Cell Reviews and ReportsQ7607285
P1476titleUnravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes
P478volume9